Sort by
Refine Your Search
-
with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by
-
prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA
-
, field-based US medical science liaison and promotional review committee and will also have the opportunity to specialize in a preferred area of medical affairs for an elective rotation. The fellow will
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Clinical Science fellowship, based in Cambridge, MA. About Alnylam Alnylam
-
, and scholarly activities. In partnership with Northeastern University, Vertex Pharmaceutical is offering a two-year Clinical Science fellowship, based in Boston, Massachusetts. About Vertex Vertex is a
-
prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA
-
clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including neuropathic pain, APOL1-mediated kidney
-
investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy
-
State of Massachusetts or Doctor of Philosophy degree in a biological or physical science. Excellent oral and written communication, time management, and leadership skills, ability to work independently
-
prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA